ADMA Biologics Inc - Company Profile
Powered by 
All the sales intelligence you need on ADMA Biologics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ADMA Biologics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ADMA Biologics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
ADMA Biologics Inc (ADMA Biologics) is a biopharmaceutical company that focuses on the manufacturing, marketing, and developing specialty biologics for treating immunodeficient patients at risk for infection and others at risk for certain infectious diseases. It serves immune-compromised individuals with underlying immune deficiency disorders or those who are immune-suppressed for medical reasons.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
ADMA Biologics is conducting research and development activities to advance plasma-based biologics for the treatment of immune deficiencies and infectious diseases. The company has developed a patented process for manufacturing unique polyclonal immune globulin products. It focuses on screening and identifying high-titer hyperimmune donors, utilizing proprietary microneutralization assays to measure titer levels of neutralizing RSV antibodies. Its customized plasma pools are created from a blend of normal and selected donor plasma to enhance antibody levels against specific pathogens. The company is committed to developing therapies for Primary Immunodeficiency (PI) patients, who are at risk of infections due to deficient immune systems. ADMA Biologics also holds intellectual property related to immunotherapeutic compositions and methods for treating and preventing infections, including S. pneumonia. As of December 2025, the company held 11 US patents, comprising eight that are related to ASCENIV and three that pertain to S. pneumonia. In FY2025, the company spent US$4.8 million on its R&D activities, which as a percentage of revenue stood at 1%.
Business Segments
Overview
Includes the company’s immune globulin manufacturing and development operations in Florida. It manufactures and sells three US food and drug administration (FDA) licensed products: - Bivigam (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI) or Primary Immunodeficiency Disease (PIDD). - Asceniv (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI in adults and adolescents. - Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Operates plasma collection facilities in the US through the ADMA BioCenters subsidiary. Plasma Collection Centers provide the company with the blood plasma required for the manufacturing of products and allows selling quantities of source and hyperimmune plasma to third-party customers for further manufacturing.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer